CervoMed Inc.
CRVO
$8.90
-$0.01-0.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.29M | -11.95M | -5.04M | -4.15M | -2.17M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 200.50K | 410.80K | -2.99M | -3.37M | -5.02M |
| Change in Net Operating Assets | -440.70K | 518.00K | 397.70K | 133.90K | -261.30K |
| Cash from Operations | -16.53M | -11.02M | -7.63M | -7.39M | -7.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.66M | -37.97M | -40.57M | -- | -- |
| Cash from Investing | -28.66M | -37.97M | -40.57M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.41M | 46.41M | 47.22M | 810.00K | 810.00K |
| Repurchase of Common Stock | -13.30K | -13.30K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -93.40K | 10.34M | 10.34M | 10.34M |
| Cash from Financing | 46.40M | 46.31M | 57.56M | 11.15M | 11.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.21M | -2.68M | 9.36M | 3.76M | 3.70M |